Thermo Fisher Scientific Receives FDA Clearance For MRSA Test Medium

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has received U.S. Food and Drug Administration (FDA) clearance for Spectra(TM) MRSA, a test designed to screen for methicillin-resistant Staphylococcus aureus (MRSA), more commonly known as the “superbug.” With the highest Positive Predictive Value commercially available for MRSA screening, Spectra provides accurate results within 24 hours.

More: continued here

Filed under: MRSA / Drug Resistance on April 4th, 2008